HIV Flashcards

1
Q

How does HIV lead to AIDS?

A

HIV attacks and destroys the infection-fighting CD4 T-cells of the immune system. The loss of CD4 cells make it difficult for the immune system to fight infections, leading to AIDS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is HIV transmitted from one person to another?

A

Having unprotected sexual intercourse with an infected person
Sharing infected syringes and needles
Mother-to-child transmission during pregnancy, at birth or through breastfeeding
Transfusion with contaminated blood and blood products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who should be tested for HIV? (8)

A
IV drug users 
Person who have unprotected sex with multiple partners
Man who have sex with man 
Commercial sex workers 
Persons treated for STDs
Recipients of multiple blood transfusion 
Persons who have been sexually assaulted
Pregnant women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of HIV infection

A

Serum antibody detection: HIV enzyme immunoassay antibody tests, Western Blot

HIV RNA detection/quantification (viral load): nucleic acid amplification (PCR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CD4 cell count for AIDS?

A

AIDS = CD4 <200/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is viral load?

A

The amount of plasma HIV RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does CD4 count indicate?

A

It is an indicator of immune function in HIV-infected patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does viral load indicate?

A

It is an indicator of response to antiretroviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When do we start ART?

A

It is recommended for all HIV-infected individuals regardless of CD4 count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the benefits of earlier treatment?

A

Prevent potentially irreversible damage to the immune system
Decreased risk for HIV-associated complications
Decreased risk for non-opportunistic conditions
Decreased risk of HIV transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 5 classes of drugs in the ART armamentarium?

A
Reverse transcriptase inhibitors 
Fusion inhibitors 
Protease inhibitors
Integrase inhibitors 
PK enhancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the recommended combinations for patients naïve to ART?

A

2 NRTI 1 INSTI
tenofovir + emtricitabine + bictegravir
tenofovir + emtricitabine + dolutegravir
abacavir + lamivudine + dolutegravir

1 NRTI 1 INSTI
emtricitabine + dolutegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs are active against HBV?

A

Emtricitabine, lamivudine, tenofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What patients are not eligible for dual therapy of emtricitabine + dolutegravir?

A

HIV RNA >500,000copies/mL
HBV coinfection
in whom ART is to be started before the results of HIV genotypic resistance testing or HBV testing are available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 5 nucleoside reverse transcriptase inhibitors?

A

Emtricitabine, tenofovir, abacavir, lamivudine, zidovudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are NRTIs cleared?

A

Renally

Dose adjustments required for renal impaired patients (except abacavir)

17
Q

What are the class disadvantages of NRTIs?

A

Adverse effects related to mitochondrial toxicity (rate but serious)
- Lactic acidosis and hepatic steatosis
- lipoatrophy
Renal dose adjustments

18
Q

What are the adverse effects of lamivudine?

A

Minimal toxicity

19
Q

What are the adverse effects of emtricitabine?

A

Minimal toxicity

20
Q

What are the adverse effects of tenofovir?

A

Renal impairment

Decrease in bone mineral density

21
Q

What are the adverse effects of abacavir?

A

Hypersensitivity reaction in patients with HLA-B*5701.

22
Q

What are the adverse effects of zidovudine?

A

Bone marrow suppression

23
Q

What are the INSTIs?

A

Bictegravir, dolutegravir, raltegravir, elvitegravir

24
Q

What is the adverse effect of raltegravir?

A

Creatinine kinase elevation (rhabdomyolysis)

25
Q

What are the NNRTIs?

A

Efavirenz, rilpivirine

26
Q

What is the adverse effect of efavirenz?

A

Neuropsychiatric SE

27
Q

What are the protease inhibitors?

A

Ritonavir, lopinavir, atazanavir, darunavir, fosamprenavr (FLARD)

28
Q

Which class of antivirals have an increased risk for lipohypertrophy?

A

Protease inhibitors

29
Q

What is a class disadvantage of PIs?

A

Increased metabolic complications like dyslipidemia and insulin resistance

30
Q

What is a fusion inhibitor?

A

Enfuvirtide

31
Q

What is an AE associated with enfuvirtide?

A

Injection site reaction (it is given SC)

32
Q

What is a CCR5 antagonist?

A

Maraviroc

33
Q

What must be done before initiation of maraviroc?

A

Co-receptor tropism assay to check what receptor the HIV uses to enter the CD4 cell (should be CCR5 receptor)

34
Q

What are the reasons for treatment failure?

A
  • Drug toxicities leads to non-adherence
  • Dosing schedule and requirements
  • Drug drug interactions
  • Viral resistance
  • Regimen potency
  • Provider experience
  • Adherence > 95%